...
首页> 外文期刊>Acta Chimica Slovenica >Encapsulation of Dirhenium(III) Carboxylates into Zirconium Phosphate
【24h】

Encapsulation of Dirhenium(III) Carboxylates into Zirconium Phosphate

机译:将甲磺酸盐(III)羧酸盐封装到磷酸锆中

获取原文

摘要

Present work reports the synthesis of zirconium phosphate nanoparticles containing dirhenium(III) substance bis-dimethylsulfoxide-cis-tetrachlorodi-μ-pivalatodirhenium(III) with formula cis -Re 2 (C(CH 3 ) 3 COO) 2 Cl 4 ?2DMSO ( I ) and q-zirconium phosphate with formula q-Zr(HPO 4 ) 2 ?6H 2 O (ZrP). The intercalation process was monitored by EAS. Due to the spectral characteristics of the quadruple bond the conclusion was made that the obtained intercalated compounds had cis -configuration of ligands around cluster dirhenium fragment. The proposed mechanism of intercalation includes the substitution of the axial ligands of I by phosphate groups of ZrP first on the surface of ZrP, than in the inner layers. Two received products of the intercalation were characterized by SEM, XRPD, FT-IR, TGA analysis witnessing about successful intercalation process. The formation of new phases with interlayer distances of 10.53 – 16.6 ? was found, the average size of obtained platelets was 100-200 nm.
机译:目前的工作报告了含有罗烯(III)物质双 - 二甲基磺砜-CIS-Tetrachlorodi-μ-戊二酮(III)的磷酸锆纳米粒子的合成,其中配合CIS -RE 2(C(CH 3)3 COO)2 Cl 4 2 -2DMSO( I)和磷酸Q-磷酸酮,用式Q-Zr(HPO 4)2→2 O(ZRP)。通过EA监测嵌入过程。由于四重粘合的光谱特性,结论是,所获得的插层化合物具有CIS-甲状腺碎片周围的配体的CISCONFIGRATION。所提出的嵌入机制包括通过首先在ZRP的表面上首先取代I通过磷酸Zrp的磷酸盐基团,而不是在内层中。两个接受的嵌入产品的特征在于SEM,XRPD,FT-IR,TGA分析见到了成功的插入过程。具有10.53 - 16.6的层间距离的新阶段的形成?发现,获得的血小板的平均尺寸为100-200nm。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号